Eurojersey sponsors running event for multiple sclerosis
With Sensitive Fabrics, Eurojersey runs with AISM at the Lenovo Relay Milano Marathon ANYWHERE on May 16th.
11th May 2021
Eurojersey, the leading Italian manufacturer of Sensitive Fabrics, has confirmed its participation as technical sponsor of AISM at this year’s special edition of the
Lenovo Relay Milano Marathon 2021, with the donation of an exclusive technical T-shirt for all athletes taking part in the event for the Italian Multiple Sclerosis Society – Province of Milan Section. A special edition, guaranteed by all the necessary safety criteria for running ANYWHERE, enables registered participants to take an active and supportive part in the relay race, wherever they are.
Hematopoietic stem cell transplants may prevent worsening of MS disability
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of
Neurology
®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more than half of the people with the secondary progressive form of MS experienced no worsening of their symptoms 10 years after a transplant.
E-Mail
MINNEAPOLIS - A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of
Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more than half of the people with the secondary progressive form of MS experienced no worsening of their symptoms 10 years after a transplant.